Cushing's disease, pseudo-Cushing states and the dexamethasone test: A historical and critical review

Pituitary

Volumn 17, Issue 4, 2014, Pages 374-380

  Lindholm, J ^a  

^a AALBORG UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Adrenal function; Cushing's syndrome; Dexamethasone test

Indexed keywords

17 HYDROXYCORTICOSTEROID; 17 OXOSTEROID; DEXAMETHASONE; FLUDROCORTISONE; GLUCOCORTICOID; GLUCOSE; HYDROCORTISONE; POTASSIUM; SODIUM; STEROID;

17-KETOSTEROID URINE LEVEL; ADRENAL CORTEX HYPERFUNCTION; ADRENAL CORTEX INSUFFICIENCY; ADRENAL CORTEX TUMOR; ADRENAL FUNCTION; ADRENAL HYPERPLASIA; ADRENAL INCIDENTALOMA; AGITATION; ALCOHOLISM; ANXIETY; BRAIN SURGERY; CANCER RADIOTHERAPY; CUSHING DISEASE; DEXAMETHASONE SUPPRESSION TEST; DIAGNOSTIC VALUE; DISEASE SEVERITY; DRUG ABSORPTION; DRUG MEGADOSE; DRUG METABOLISM; EVENING DOSAGE; FEAR; GLUCOSE TOLERANCE TEST; HORMONE INHIBITION; HOSPITALIZATION; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYDROCORTISONE RELEASE; HYDROCORTISONE URINE LEVEL; HYPERCORTISOLISM; HYPERTENSION; HYPOPHYSIS SURGERY; HYPOPHYSIS TUMOR; LOW DRUG DOSE; MAJOR DEPRESSION; MALIGNANT NEOPLASTIC DISEASE; MATHEMATICAL ANALYSIS; METABOLITE; OSTEOPENIA; PATHOPHYSIOLOGY; PATIENT MONITORING; PHYSICAL DISABILITY; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; PSEUDOCUSHING STATE; RELIABILITY; REVIEW; SENSITIVITY AND SPECIFICITY; SODIUM BLOOD LEVEL; STEROID EXCRETION; WELLBEING; ADRENAL GLAND; DRUG EFFECTS; FEMALE; MALE; METABOLISM; PITUITARY ACTH HYPERSECRETION;

ADRENAL GLANDS; DEXAMETHASONE; FEMALE; HUMANS; MALE; PITUITARY ACTH HYPERSECRETION;

EID: 84904126560     PISSN: 1386341X     EISSN: 15737403     Source Type: Journal    
DOI: 10.1007/s11102-013-0509-x     Document Type: Review

References (63)

1. Lindholm J (2000) Cushing's syndrome: historical aspects. Pituitary 3:97-104
2. Cushing H (1912) The pituitary body and its disorders, clinical states produced by disorders of the hypophysis cerebri. Lippincott, Philadelphia, pp 1-341
3. Cushing H (1932) The basophilic adenomas of the pituitary body and their clinical manifestations (pituitary basophilism). Bull Johns Hopkins Hosp 50:137-195
4. Kepler EJ (1949) Cushing's disease: a primary disorder of the adrenal cortices. Ann NY Acad Sci 50:657-678
5. Bauer J (1950) The so-called Cushing's syndrome, its history, terminology and differential diagnosis. Acta Med Scand 137:411-416
6. Norymberski JD, Stubbs RD, West HE (1953) Assessment of adrenocortical activity by assay of 17-ketogenic steroids in urine. Lancet 261:1276-1281
7. Porter CC, Silber RH (1950) A quantitative color reaction for cortisone and related 17:21-dihydroxy-20-ketosteroids. J Biol Chem 185:201-207
8. Schteingart DE, Gregerman RI, Conn JW (1963) A comparison of the characteristics of increased adrenocortical function in obesity and in Cushing's syndrome. Metabolism 12:484-497
9. Cope CL, Black EG (1959) The reliability of some adrenal function tests. BMJ 2:1117-1122
10. Beisel WR, Cos JJ, Horton R, Chao PY, Forsham PH (1964) Physiology of urinary cortisol. J Clin Endocrinol Metabol 24:887-893
11. Lindholm J (1973) The urinary excretion of cortisol. Scand J Lab Clin Invest 31:115-118
12. Wilkins L, Lewis R, Klein R, Rosenberg E (1950) The suppression of androgen secretion by cortisone in a case of congenital adrenal hyperplasia. Bull Johns Hopkins Hosp 86:249-252
13. Jailer JW, Louchart J, Cahill GF (1952) Adrenal virilism. 1 Diagnostic consideration and treatment. JAMA 150:575-579
14. Segaloff A, Gordon D, Horwitt BN (1955) Differential diagnosis of adrenal lesions by the use of intravenous administration of hydrocortisone. J Lab Clin Med 45:219-227
15. Jailer JW, Louchart JWT, Gold JJ, Knowlton A, Cahill GF (1953) The effect of cortisone on the urinary excretion of 17-ketosteroids in patients with Cushing's syndrome. J Clin Invest 32:449-451
16. Jailer JW, Gold JJ, Wallace EZ (1954) Evaluation of the "cortisone test" as a diagnostic aid in differentiating adrenal hyperplasia from adrenal neoplasia. Am J Med 16:340-345
17. Cope CL, Harrison RJ (1955) Effect of 9α-fluoro hydrocortisone on adrenal hyperfunction in Cushing's syndrome. BMJ 2:457-460
18. Liddle GW (1960) Tests of pituitary-adrenal suppressibility in the diagnosis of Cushing's syndrome. J Clin Endocrinol Metabol 20:1539-1560
19. Nugent CA, Nichols T, Tayler FH (1965) Diagnosis of Cushing's syndrome: single dose dexamethasone suppression test. Arch Intern Med 116:172-176
20. Pavlatos FC, Smilo RP, Forsham PH (1965) A rapid screening test for Cushing's syndrome. JAMA 193:720-723
21. Kennedy L, Atkinson AB, Johnston H, Sheridan B, Hadden DR (1984) Serum cortisol concentrations during low dose dexamethasone suppression test to screen for Cushing's syndrome. BMJ (Clin Res Ed) 289:1188-1191 (Pubitemid 15208149)
22. Odagiri E, Demura R, Demura H, Suda T, Ishiwatari N, Abe Y, Jibiki K, Shizume K (1988) The changes in plasma cortisol and urinary free cortisol by an overnight dexamethasone suppression test in patients with Cushing's disease. Endocrinol Jpn 35:795-802 (Pubitemid 20034068)
23. Barth JH, Seth J, Howlett TA, Freedman DB (1995) A survey of endocrine function testing by clinical biochemistry laboratories in the UK. Ann Clin Biochem 32:442-449
24. Cope CL (1966) The adrenal cortex in internal medicine I. BMJ 2:847-853
25. Burke CW, Beardwell CG (1973) Cushing's syndrome. An evaluation of the clinical usefulness of urinary free cortisol and other urinary steroid measurements in diagnosis. QJM 42:175-204
26. Meikle AW (1982) Dexamethasone suppression tests: usefulness of simultaneous measurement of plasma cortisol and dexamethasone. Clin Endocrinol 16:401-408
27. Croughs RJ, Docter R, de Jong FH (1973) Comparison of oral and intravenous dexamethasone suppression tests in the differential diagnosis of Cushing's syndrome. Acta Endocrinol 72:54-62
28. Orth DN (1984) The old and the new in Cushing's syndrome. N Engl J Med 310:649-657
29. Eddy RL, Jones AL, Gilliland PF, Ibarra JD, Thompson JQ, McMurry JF (1973) Cushing's syndrome: a prospective study of diagnostic methods. Am J Med 55:621-630
30. Tran HA, Petrovsky N (2005) Dexamethasone infusion testing in the diagnosis of Cushing's syndrome. Endocr J 52:103-109 (Pubitemid 40410325)
31. McHardy-Young S, Harris PWR, Lessof MH, Lyne G (1967) Single-dose dexamethasone suppression test for Cushing's syndrome. BMJ 2:740-744
32. Nieman LK (2002) Diagnostic tests for Cushing's syndrome. Ann NY Acad Sci 970:112-118
33. Arnaldi G, Angeli A, Atkinson AB, Bertagna X, Cavagnini F, Chrousos GP, Fava GA, Findling JW, Gaillard RC, Grossman AB, Kola B, Lacroix A, Mancini T, Mantero F, Newell-Price J, Nieman LK, Sonino N, Vance ML, Giustina A, Boscaro M (2003) Diagnosis and complications of Cushing's syndrome: a consensus statement. J Clin Endocrinol Metab 88:5593-5602 (Pubitemid 38033020)
34. Isidori AM, Kaltsas GA, Mohammed S, Morris DG, Jenkins P, Chew SL, Monson JP, Besser GM, Grossman AB (2003) Discriminatory value of the low-dose dexamethasone suppression test in establishing the diagnosis and differential diagnosis of Cushing's syndrome. J Clin Endocrinol Metabol 88:5299-5306 (Pubitemid 37452731)
35. Newell-Price J, Bertagna X, Grossman AB, Nieman LK (2006) Cushing's syndrome. Lancet 367:1605-1617 (Pubitemid 43674231)
36. Kola B, Grossman AB (2008) Dynamic testing in Cushing's syndrome. Pituitary 11:155-162
37. Nieman LK, Biller BM, Findling JW, Newell-Price J, Savage MO, Stewart PM, Montori VM (2008) The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metabol 93:1526-1540 (Pubitemid 351656485)
38. Suda T, Kageyama K, Nigawara T, Sakihara S (2009) Evaluation of diagnostic tests for ACTH-dependent Cushing's syndrome. Endocr J 56:469-476
39. Branconnier RJ, Oxenkrug GF, McIntyre I, Pomara N, Harto NE, Gershon S (1984) Prediction of serum cortisol response to dexamethasone in normal volunteers: a multivariate approach. Psychopharmacology 84:274-275 (Pubitemid 14006585)
40. Lindholm J (1992) Endocrine studies in patients with Cushing's disease before and after treatment. Clin Endocrinol 36:151-159
41. Findling JW, Raff H, Aron DC (2004) The low-dose dexamethasone suppression test: a reevaluation in patients with Cushing's syndrome. J Clin Endocrinol Metabol 89:1222-1226 (Pubitemid 38368417)
42. Friedman TC (2006) An update on the overnight dexamethasone suppression test for the diagnosis of Cushing's syndrome: limitations in patients with mild and/or episodic hypercortisolism. Exp Clin Endocrinol Diabetes 114:356-360
43. Board F, Wadeson R, Hamburg D (1956) Psychological stress and endocrine functions. Psychosom Med 18:324-333
44. Carroll BJ, Martin FI, Davies B (1968) Resistance to suppression by dexamethasone of plasma 11-OHCS levels in severe depressive illness. BMJ 3:285-287
45. Georgotas A, McCue RE, Kim OM, Hapworth WE, Reisberg B, Stoll PM, Sinaiko E, Fanelli C, Stokes PE (1986) Dexamethasone suppressionin dementia, depression, and normal aging. Am J Psychiatry 143:452-456 (Pubitemid 16119750)
46. Coppen A, Abou-Saleh M, Milln P, Metcalfe M, Harwood J, Bailey J (1983) Dexamethasone suppression test in depression and other psychiatric illness. Br J Psychiatry 142:498-504 (Pubitemid 13089129)
47. Gruen PH (1978) Endocrine changes in psychiatric diseases. Med Clin N Am 62:285-295
48. Brouwer JP, Appelhof BC, Hoogendijk WJ, Huyser J, Endert E, Zuketto C, Schene AH, Tijssen JG, Van Dyck R, Wiersinga WM, Fliers E (2005) Thyroid and adrenal axis in major depression: a controlled study in outpatients. Eur J Endocrinol 152:185-191 (Pubitemid 40309563)
49. Rush A, Giles D, Schlesser M, Orsulak P, Weissenburger J, Fulton C, Fairchild C, Roffwarg H (1997) Dexamethasone response, thyrotropin-releasing hormone stimulation, rapid eye movement latency, and subtypes of depression. Biol Psychiatry 41:915-928 (Pubitemid 27213702)
50. Hasselbalch H, Selmer J, Sestoft L, Kehlet H (1982) Hypothalamic- pituitary-adrenocortical function in chronic alcoholism. Clin Endocrinol 16:73-76 (Pubitemid 12200729)
51. Davis JRE, Jeffcoate WJ (1983) Lack of effect of ethanol on plasma cortisol in man. Clin Endocrinol 19:461-466 (Pubitemid 13001507)
52. Bishop MC, Ross EJ (1971) Adrenocortical activity in disseminated malignant disease in relation to prognosis. Br J Cancer 25:719-725
53. Jenkins PJ, Sohaib SA, Trainer PJ, Lister TA, Besser GM, Reznek R (1999) Adrenal enlargement and failure of suppression of circulating cortisol by dexamethasone in patients with malignancy. Br J Cancer 80:1815-1819 (Pubitemid 29389638)
54. Reincke M, Allolio B, Wurth G, Winkelmann W (1993) The hypothalamic-pituitary-adrenal axis in critical illness: response to dexamethasone and corticotropin-releasing hormone. J Clin Endocrinol Metab 77:151-156 (Pubitemid 23206794)
55. Perrot D, Bonneton A, Dechaud H, Motin J, Pugeat M (1993) Hypercortisolism in septic shock is not suppressible by dexamethasone infusion. Crit Care Med 21:396-401 (Pubitemid 23097037)
56. Chiodini I (2011) Diagnosis and treatment of subclinical hypercortisolism. J Clin Endocrinol Metab 96:1223-1236
57. Arnaldi G, Boscaro M (2012) Adrenal incidentaloma. Best Pract Res Clin Endocrinol Metab 26:405-419
58. Stewart PM (2010) Is subclinical Cushing's syndrome an entity or a statistical fallout from diagnostic testing? Consensus surrounding the diagnosis is required before optimal treatment can be defined. J Clin Endocrinol Metabol 95:2618-2620
59. Tyrrell JB, Findling JW, Aron DC, Fitzgerald PA, Forsham PH (1986) An overnight high-dose dexamethasone suppression test for rapid differential diagnosis of Cushing's syndrome. Ann Intern Med 104:180-186 (Pubitemid 16134700)
60. Grossman AB, Howlett TA, Perry L, Coy DH, Savage MO, Lavender P, Rees LH, Besser GM (1988) CRF in the differential diagnosis of Cushing's syndrome: a comparison with the dexamethasone suppression test. Clin Endocrinol 29:167-178
61. Blunt SB, Sandler LM, Burrin JM, Joplin GF (1990) An evaluation of the distinction of ectopic and pituitary ACTH dependent Cushing's syndrome by clinical features: biochemical tests and radiological findings. QJM 77:1113-1133 (Pubitemid 20379531)
62. Al-Saadi N, Diederich S, Oelkers W (1998) A very high dose dexamethasone suppression test for differential diagnosis of Cushing's syndrome. Clin Endocrinol 48:45-51 (Pubitemid 28122432)
63. Lindholm J, Juul S, Jørgensen JOL, Astrup J, Bjerre P, Hagen C, Jørgensen J, Kosteljanetz M, Kristensen LØ, Laurberg P, Feldt-Rasmussen U, Schmidt K, Weeke J (2001) Incidence and late prognosis of Cushing's syndrome: a population based study. J Clin Endocrinol Metabol 86:117-123 (Pubitemid 32111743)